HealthcareLarge capRs 37,108 crRs 51.0 cr traded a day
Close on 2026-08-21
1,815.80
+0.92%
52-week range44% of the way up
1,605.302,080.30
Market cap
37,108 cr
P/E (TTM)
45.4×
industry 44×
EPS (TTM)
39.96
Revenue YoY
+78.0%
Q1 FY27
Profit YoY
+5.4%
Net margin
7.7%
-5.3pt vs a year ago
Growth trend
+2.2pt
vs last quarter’s YoY
1 month
-8.4%
Below 52w high
14.6%
RSI (14)
23
oversold
Daily swing
1.9%
average true range
Volume
0.6×
vs 20-day average
Traded
Rs 51 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−0.92%
1 month
−8.41%
3 months
−4.00%
6 months
−1.92%
1 year
+2.80%
The read
written from the numbers on this page
The evidence is mixed3 supporting, 3 against, 1 worth knowing
Supporting
up 3% over twelve months
3 independent kinds of evidence agree today, which is uncommon
revenue grew 78% year on year in the quarter ending 2026-06-30
Against
trading 2% below its 200-day average
1 of the scans it matches has historically underperformed the market
net margin has narrowed from 15.7% to 7.7% across four quarters
Worth knowing
RSI at 23 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 1,856, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working2
Revenue +78.0% year on year, Rs 1,507 cr to Rs 2,684 cr.
+78.0%Rs 1,507 crRs 2,684 cr
Net profit +5.4% year on year, Rs 197 cr to Rs 207 cr.
+5.4%Rs 197 crRs 207 cr
Needs watching2
Profit grew slower than revenue, +5.4% against +78.0%.
+5.4%+78.0%
Net margin moved from 13.1% to 7.7%.
13.1%7.7%
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
6 of 47 matched on 2026-08-21
NH matches 6 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
NH trades at 45× trailing earnings, close to its median of 46× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362) · Analyst call filings were typically +0.14pt vs the market over the next 5 sessions (n=3,352)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 78% against the same quarter a year earlier
profit rose 5% year on year
revenue rose in 4 of the last 4 quarters
Going against it
net margin narrowed from 8.6% to 7.7%
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
2,684
262
207
10.20
7.7%
Q4 FY26
2026-03-31 · consolidated
2,594
294
224
11.22
8.6%
Q3 FY26
2025-12-31 · consolidated
2,151
152
127
6.30
5.9%
Q2 FY26
2025-09-30 · consolidated
1,644
297
258
12.71
15.7%
Q1 FY26
2025-06-30 · consolidated
1,507
231
197
9.65
13.1%
Q4 FY25
2025-03-31 · consolidated
1,475
253
197
9.66
13.4%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-6.4%
Versus 200-day average-2.2%
Below 52-week high-12.7%
Above 52-week low+13.1%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)23.5
Higher closes in last 52 of 5
Six-month return−1.92%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)1.93%
Volume versus 20-day0.6x
Median daily turnoverRs 51.0 cr
Peers
Healthcare · 67 classified companies
NH trades at 45.4× trailing earnings against an industry median of 44.0× across 64 other classified companies in its industry — priced roughly in line with them. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.